Researchers have been spending several decades to identify effective agents against cancer which is one of the leading causes of death worldwide. Thus, about 60% of anticancer drugs are structural modification and their analogues from the natural sources such as vinblastine, taxol and camptothecin. However, the management of cancer is still not up to mark and always needs to find out new chemotherapeutic agents. In continuation to our previous investigation on the bioactivities of pistagremic acid , which was evaluated for its cytotoxic effects against NCI 60-cell panel on eight organs (leukemia, non-small cell lung cancer, colon, CNS, melanoma, ovarian, prostate, renal and breast) at National Cancer Institute (NCI) USA, showed significant inhibition to human cancer cell lines.
Last date updated on June, 2014